Female gender doubles executive dysfunction risk in ALS:A case-control study in 165 patients

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 5, 2015, Pages 574-579

  Palmieri, Arianna ^a   Mento, Giovanni ^a   Calvo, Vincenzo ^a   Querin, Giorgia ^a   D'Ascenzo, Carla ^a   Volpato, Chiara ^b   Kleinbub, Johann Roland ^a   Bisiacchi, Patrizia Silvia ^a   Sorarù, Gianni ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE DYSFUNCTION; EXECUTIVE FUNCTION; FEMALE; GENDER; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; AGED; COMPLICATION; MIDDLE AGED; PSYCHOLOGY; SEXUAL DEVELOPMENT;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 84927585746     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-307654     Document Type: Article

References (40)

1. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012;83:102-8.
2. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131-46.
3. Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80:1590-7.
4. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263-9.
5. Palmieri A, Soraru G, D'Ascenzo C, et al. Specifi c numerical processing impairment in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:6-12.
6. Cavallo M, Adenzato M, MacPherson SE, et al. Evidence of social understanding impairment in patients with amyotrophic lateral sclerosis. PLoS ONE 2011;6:e25948.
7. Kocoska-Maras L, Rådestad AF, Carlström K, et al. Cognitive function in association with sex hormones in postmenopausal women. Gynecol Endocrinol 2013;29:59-62.
8. McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med 2010;7:557-70.
9. Cima V, Logroscino G, D'Ascenzo C, et al. Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur J Neurol 2009;16:920-4.
10. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
11. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
12. Rajagopalan V, Pioro EP. Distinct patterns of cortical atrophy in ALS patients with or without dementia: an MRI VBM study. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:216-25.
13. Seelaar H, Rohrer JD, Pijnenburg YA, et al. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2011;82:476-86.
14. Abrahams S, Leigh PN, Harvey A, et al. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 2000;38:734-47.
15. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976;12:313-24.
16. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-6.
17. Sánchez-Cubillo I, Periánez JA, Adrover-Roig D, et al. Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc 2009;15:438-50.
18. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987;8(Suppl):1-120.
19. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Fabiger, 1978.
20. Raven JC. Guide to using the coloured progressive matrices. New York: The Psychological Corporation, 1965.
21. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
22. Blasco H, Guennoc AM, Veyrat-Durebex C, et al. Amyotrophic lateral sclerosis: a hormonal condition? Amyotroph Lateral Scler 2012;13:585-8.
23. Czlonkowska A, Ciesielska A, Gromadzka G, et al. Estrogen and cytokines production-the possible cause of gender differences in neurological diseases. Curr Pharm Des 2005;11:1017-30.
24. Singh M, Su C. Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy. Brain Res 2013;1514:98-106.
25. Bourque M, Dluzen DE, Di Paolo T. Neuroprotective actions of sex steroids in Parkinson' s disease. Front Neuroendocrinol 2009;30:142-57.
26. D 'Ascenzo C, Cecchin D, Santelli L, et al. Parkinson-like features in ALS with predominant upper motor neuron involvement. Amyotroph Lateral Scler 2012;13:137-43.
27. Mosca L, Lunetta C, Tarlarini C, et al. Wide phenotypic spectrum of the TARDBP gene: homozygosity of A382T mutation in a patient presenting with amyotrophic lateral sclerosis, Parkinson's disease, and frontotemporal lobar degeneration, and in neurologically healthy subject. Neurobiol Aging 2012;33:1846.e1841-4.
28. Trieu VN, Uckun FM. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun 1999;258:685-8.
29. Shahrokhi N, Haddad MK, Joukar S, et al. Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury. Pak J Pharm Sci 2012;25: 219-25.
30. Frutiger K, Lukas TJ, Gorrie G, et al. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;9:184-7.
31. Van Dyke SA, Zuverza V, Hill LA, et al. Gender differences in lateralized semantic priming. Dev Neuropsychol 2009;34:381-92.
32. Fornito A, Whittle S, Wood SJ, et al. The influence of sulcal variability on morphometry of the human anterior cingulate and paracingulate cortex. Neuroimage 2006;33:843-54.
33. Fornito A, Wood SJ, Whittle S, et al. Variability of the paracingulate sulcus and morphometry of the medial frontal cortex: associations with cortical thickness, surface area, volume, and sulcal depth. Hum Brain Mapp 2008;29:222-36.
34. Yucel M, Stuart GW, Maruff P, et al. Hemispheric and gender-related differences in the gross morphology of the anterior cingulate/paracingulate cortex in normal volunteers: an MRI morphometric study. Cereb Cortex 2001;11:17-25.
35. Huster RJ, Westerhausen R, Herrmann CS. Sex differences in cognitive control are associated with midcingulate and callosal morphology. Brain Struct Funct 2011;215:225-35.
36. Turner MR, Grosskreutz J, Kassubek J, et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 2011;10:400-3.
37. Palmieri A, Naccarato M, Abrahams S, et al. Right hemisphere dysfunction and emotional processing in ALS: an fMRI study. J Neurol 2010;257:1970-8.
38. Grosskreutz J, Kaufmann J, Fradrich J, et al. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol 2006;6:17.
39. Murphy JM, Henry RG, Langmore S, et al. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007;64:530-4.
40. Dolcos F, Rice HJ, Cabeza R. Hemispheric asymmetry and aging: right hemisphere decline or asymmetry reduction. Neurosci Biobehav Rev 2002;26:819-25.